Trials / Completed
CompletedNCT05791669
Arrest of Interproximal Caries Lesion With 38% Silver Diamine Fluoride Solution
Arrest of Interproximal Caries Lesion in Primary Molars With 38% Silver Diamine Fluoride Solution and 5% Sodium Fluoride Varnish: A Randomized Clinical Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Postgraduate Institute of Dental Sciences Rohtak · Academic / Other
- Sex
- All
- Age
- 5 Years – 9 Years
- Healthy volunteers
- Not accepted
Summary
This study was conducted to assess the efficacy of 38% Silver Diamine fluoride and compare it with 5% sodium fluoride varnish in arresting interproximal caries in primary molars at 12 months follow-up. Bitewing radiographs were taken to diagnose as well as to assess caries depth at follow up visits. Each bitewing was scored based on ICCMS radiographic criteria and was compared (follow-ups to baseline)to check for caries arrest. Interproximal caries included in this study, according to ICCMS criteria, were at stages- RA - caries limited to outer half of enamel RA2 - caries limited to the inner half of enamel RA3 - caries limited to outer third of dentine RA4 - caries limited to middle third of dentine
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Silver diamine fluoride | Silver diamine fluoride is a topical medication composed of 25% silver, 5% fluoride, 8% ammonia, and 62% Deionized water, used to treat and prevent dental caries and relieve dentinal hypersensitivity. |
| DRUG | Sodium fluoride varnish | It is a topical application with an active ingredient of 5% sodium fluoride(22,600ppm fluoride).it prolongs the contact time between the fluoride and tooth surface and promotes remineralization and inhibits demineralization. |
Timeline
- Start date
- 2021-08-01
- Primary completion
- 2022-08-02
- Completion
- 2022-11-08
- First posted
- 2023-03-30
- Last updated
- 2023-03-30
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT05791669. Inclusion in this directory is not an endorsement.